Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.
Step 1 – Issue Identification & Review
The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.
• Review the issues identified by the AI • Add, edit, remove, or refine issues as required
Step 2 – Draft Generation
Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.
• Relevant statutory provisions • Judicial precedents and Supreme Court, High Court and other citations • Issue-wise legal analysis • Practical arguments and supporting content • Professionally structured draft ready for further review.
Supreme Court clarifies classification of Vitamin B combinations, resolves conflicting decisions The Supreme Court resolved the issue by upholding the classification of fixed dose combinations of Vitamin B-1, B-6, and B-12 injectible and tablets under ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Supreme Court clarifies classification of Vitamin B combinations, resolves conflicting decisions
The Supreme Court resolved the issue by upholding the classification of fixed dose combinations of Vitamin B-1, B-6, and B-12 injectible and tablets under Heading 3003.10, as claimed by the assessee. The conflicting decisions of the Tribunal Benches were reconciled through a larger Bench decision, which the Revenue accepted. Consequently, the appeals filed by the assessee were allowed, while the Revenue's appeal was dismissed, providing clarity and consistency in the classification of such goods.
Issues involved: Classification of fixed dos combination of Vitamin B-1, B-6 and B-12 injectible and tablets under Chapter Heading 2936.00 or Heading 3003.10.
The Supreme Court heard two appeals regarding the classification of fixed dose combinations of Vitamin B-1, B-6, and B-12 injectible and tablets. The issue was that two different Tribunal Benches had given contradictory decisions on the classification of these goods. The Delhi Bench classified the goods under Chapter Heading 2936.00, supporting the Revenue's case, while the Mumbai Bench classified the same goods under Heading 3003.10, as claimed by the assessee. Due to this conflict, the matter was referred to a larger Bench, which resolved the issue in the case of Micropure Parenterals Pvt. Ltd. vs. Commissioner of Central Excise, Mumbai-III. The respondent held that the goods should be classified under Heading 3003.10, in line with the assessee's claim. Notably, the Revenue did not appeal the decision and accepted the classification under Heading 3003.10. Consequently, the appeals filed by the assessee were allowed, while the appeal filed by the Revenue was dismissed.
In conclusion, the Supreme Court resolved the issue of classification of fixed dose combinations of Vitamin B-1, B-6, and B-12 injectible and tablets by upholding the classification under Heading 3003.10, as claimed by the assessee. The conflicting decisions of the two Tribunal Benches were reconciled through reference to a larger Bench decision, which was accepted by the Revenue. This judgment provides clarity on the classification of these goods, ensuring consistency in future cases.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
AI Drafter ✕
TaxTMI 
TaxTMI 
